More than 1,900 Xarelto (rivaroxaban) lawsuits have been filed against Bayer and Johnson & Johnson (J&J), and the number is expected to pass 2,000 soon. A recently published study, funded by Bayer, concluded that Xarelto is safe. Several other studies, not funded by the drug maker, came to far less favorable conclusions. Xarelto can cause … [Read more...]
The Mounting Case against Xarelto from FDA Direct Adverse Drug Reports
In just the last four years, the FDA has raised many separate clarifications with Johnson & Johnson about the blood thinning drug Xarelto. These have included extra black box warnings about the possible contraindications, additional advertising requirements and further possible side effects that were not included on the original FDA approval in … [Read more...]
J&J Spends Hundreds of Millions to Promote Xarelto, The Blood Thinner that Kills
The blood thinner market in the United States was worth over $8 billion in 2012 and is expected to grow to over $15 billion by 2018, according to a June 2013 report by pharmaceutical analysts EvaluatePharma. Xarelto, one of a new type of anti-coagulants that doesn't require individual dosing (unlike category leader Warfarin) is big business for … [Read more...]
Xarelto Dangers
Xarelto (rivaroxaban) is a popular anti-clotting drug that is prescribed as a more convenient option than older anti-coagulants such as warfarin. Janssen Pharmaceuticals, Inc., a subsidiary of Johnson & Johnson, tells consumers that Xarelto will free you from the routine blood monitoring necessary with older blood thinners and that it is the … [Read more...]
Recent Comments